Lee S K, Chen K W, Schröder R. "Method for the Synthesis of (1-Methyl-3-(pyridin-3-yl)-1H-pyrazol-4-yl)methanamine" [P]. US Patent, US 11289728 B2, 2020-08-18.
发明人韩伟,刘建华,罗永刚. "A Process for Preparing High-Purity (1-Methyl-3-(pyridin-3-yl)-1H-pyrazol-4-yl)methanamine" [P]. 中国发明专利, 专利号 CN 109197483 B, 授权公告日 2015-07-07.
参考文献 Literature
Mueller T, Schmidt R K. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Talanta, 2015, 575, (9), 7052-7075.
Kumar A, Sharma P, Patel R S. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Pharm. Biomed. Anal., 2010, 1621, (2), 2133-2159.
Kumar A, Sharma P, Patel R S. "Identification and Structural Characterization of a Novel Degradation Product of (1-Methyl-3-(pyridin-3-yl)-1H-pyrazol-4-yl)methanamine Using HRMS and NMR". J. Sep. Sci., 2020, 1907, (1), 9942-9947.
Brown R C, Davis S M. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2013, 2264, 3613-3617.